Total Funding
18
53
Total FundingSeries B raised
Growth Score 18 in past quarter
2 pts
Heat Score 53 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85037
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis.
Renee A. Hart: Managing Director, Advisor
Sean J. Hart: Chief Executive Officer & Chief Scientific Officer
About the Company
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis and sorting. Its patented technology empowers researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Its technology is intended to significantly broaden the horizons of medical
research and shorten the time to powerful medical breakthroughs.
Women Founded